enVVeno Medical Corp financial data

Symbol
NVNO on Nasdaq, NVNBW on OTC
Location
70 Doppler, Irvine, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Oct 30, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.64K % -37.8%
Debt-to-equity 8.04 % +33.6%
Return On Equity -61.5 % -26.1%
Return On Assets -56.9 % -23.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 20.2M shares +15.3%
Common Stock, Shares, Outstanding 20.2M shares +15.3%
Entity Public Float 68.9M USD +136%
Weighted Average Number of Shares Outstanding, Basic 20.2M shares +25.4%
Weighted Average Number of Shares Outstanding, Diluted 20.2M shares +25.4%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 11.5M USD -1.42%
Operating Income (Loss) -23.6M USD -0.77%
Nonoperating Income (Expense) 1.62M USD -25.2%
Net Income (Loss) Attributable to Parent -22M USD -3.42%
Earnings Per Share, Basic -1 USD/shares +15.6%
Earnings Per Share, Diluted -1 USD/shares +15.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.54M USD -91.4%
Assets, Current 31.5M USD -35.8%
Property, Plant and Equipment, Net 82K USD -62.4%
Operating Lease, Right-of-Use Asset 740K USD -32.1%
Assets 32.4M USD -35.8%
Accounts Payable, Current 1.7M USD +239%
Liabilities, Current 2.4M USD +7.67%
Operating Lease, Liability, Noncurrent 505K USD -36.2%
Liabilities 2.91M USD -3.81%
Retained Earnings (Accumulated Deficit) -168M USD -15.1%
Stockholders' Equity Attributable to Parent 29.4M USD -37.8%
Liabilities and Equity 32.4M USD -35.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -4.02M USD -13.2%
Net Cash Provided by (Used in) Financing Activities 46K USD
Net Cash Provided by (Used in) Investing Activities 5.2M USD +137%
Common Stock, Shares Authorized 250M shares 0%
Common Stock, Shares, Issued 20.2M shares +15.3%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 1.18M USD
Interest Paid, Excluding Capitalized Interest, Operating Activities 45K USD +800%
Deferred Tax Assets, Gross 30.6M USD +20.4%
Operating Lease, Liability 1.06M USD -24.1%
Depreciation 100K USD 0%
Payments to Acquire Property, Plant, and Equipment 10K USD +100%
Lessee, Operating Lease, Liability, to be Paid 1.13M USD -25.6%
Property, Plant and Equipment, Gross 1.44M USD +1.84%
Operating Lease, Liability, Current 286K USD -19.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 411K USD +3.01%
Lessee, Operating Lease, Liability, to be Paid, Year One 399K USD +3.1%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 61K USD -44.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 315K USD -23.4%
Deferred Tax Assets, Operating Loss Carryforwards 22.2M USD +28.6%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 315K USD -23.4%
Additional Paid in Capital 197M USD +2.09%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 30.3M USD +21.8%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%